Your search returned 28 results.

Results
	1.	The effect of aging on OX40 agonist-mediated cancer immunotherapy. [electronic resource] by Ruby, Carl E Weinberg, Andrew D Producer: 20091204 In: Cancer immunology, immunotherapy : CII vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	OX40-enhanced tumor rejection and effector T cell differentiation decreases with age. [electronic resource] by Ruby, Carl E Weinberg, Andrew D Producer: 20090330 In: Journal of immunology (Baltimore, Md. : 1950) vol. 182 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-alpha and anti-CD40-induced activation of NF-kappaB/Rel in dendritic cells: p50 homodimer activation is not affected. [electronic resource] by Ruby, Carl E Leid, Mark Kerkvliet, Nancy I Producer: 20020905 In: Molecular pharmacology vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Impact of aging on cancer immunity and immunotherapy. [electronic resource] by Pawelec, Graham Lustgarten, Joseph Ruby, Carl Gravekamp, Claudia Producer: 20091204 In: Cancer immunology, immunotherapy : CII vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	The role of OX40-mediated co-stimulation in T-cell activation and survival. [electronic resource] by Redmond, William L Ruby, Carl E Weinberg, Andrew D Producer: 20090903 In: Critical reviews in immunology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	2,3,7,8 Tetrachlorodibenzo-p-Dioxin (TCDD) Directly Enhances the Maturation and Apoptosis of Dendritic Cells In Vitro. [electronic resource] by Ruby, Carl E Funatake, Castle J Kerkvliet, Nancy I Producer: 20121002 In: Journal of immunotoxicology vol. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	TroVax(®) vaccine therapy for renal cell carcinoma. [electronic resource] by Zhang, Rui-Tao Bines, Steven D Ruby, Carl Kaufman, Howard L Producer: 20120511 In: Immunotherapy vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Contrasting the roles of costimulation and the natural adjuvant lipopolysaccharide during the induction of T cell immunity. [electronic resource] by Maxwell, Joseph R Ruby, Carl Kerkvliet, Nancy I Vella, Anthony T Producer: 20020517 In: Journal of immunology (Baltimore, Md. : 1950) vol. 168 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses. [electronic resource] by Ruby, Carl E Redmond, William L Haley, Daniel Weinberg, Andrew D Producer: 20070216 In: European journal of immunology vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma. [electronic resource] by Kaufman, Howard L Ruby, Carl E Hughes, Tasha Slingluff, Craig L Producer: 20140627 In: Journal for immunotherapy of cancer vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Early-onset age-related changes in dendritic cell subsets can impair antigen-specific T helper 1 (Th1) CD4 T cell priming. [electronic resource] by Farazi, Michelle Cohn, Zachary Nguyen, Justine Weinberg, Andrew D Ruby, Carl E Producer: 20140929 In: Journal of leukocyte biology vol. 96 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	IL-12 is required for anti-OX40-mediated CD4 T cell survival. [electronic resource] by Ruby, Carl E Montler, Ryan Zheng, Rongxui Shu, Suyu Weinberg, Andrew D Producer: 20080417 In: Journal of immunology (Baltimore, Md. : 1950) vol. 180 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen-stimulated T cells leading to an increase in cell survival. [electronic resource] by Vasilevsky, Nicole A Ruby, Carl E Hurlin, Peter J Weinberg, Andrew D Producer: 20110602 In: European journal of immunology vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Optimal management of metastatic melanoma: current strategies and future directions. [electronic resource] by Batus, Marta Waheed, Salman Ruby, Carl Petersen, Lindsay Bines, Steven D Kaufman, Howard L Producer: 20140121 In: American journal of clinical dermatology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin. [electronic resource] by Turturro, Sanja B Najor, Matthew S Ruby, Carl E Cobleigh, Melody A Abukhdeir, Abde M Producer: 20161213 In: Breast cancer research and treatment vol. 156 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging. [electronic resource] by Farazi, Michelle Nguyen, Justine Goldufsky, Josef Linnane, Stephanie Lukaesko, Lisa Weinberg, Andrew D Ruby, Carl E Producer: 20140717 In: Cancer immunology, immunotherapy : CII vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor. [electronic resource] by Gough, Michael J Ruby, Carl E Redmond, William L Dhungel, Birat Brown, Alexis Weinberg, Andrew D Producer: 20080805 In: Cancer research vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells. [electronic resource] by Kim, Dae Won Zloza, Andrew Broucek, Joseph Schenkel, Jason M Ruby, Carl Samaha, Georges Kaufman, Howard L Producer: 20141215 In: Journal of translational medicine vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines. [electronic resource] by Goldufsky, Joe Wood, Stephen Hajihossainlou, Behnam Rehman, Tooba Majdobeh, Omar Kaufman, Howard L Ruby, Carl E Shafikhani, Sasha H Producer: 20150330 In: Journal of medical microbiology vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. [electronic resource] by Maxwell, Joseph R Yadav, Rajwardhan Rossi, Robert J Ruby, Carl E Weinberg, Andrew D Aguila, Hector L Vella, Anthony T Producer: 20060809 In: Journal of immunology (Baltimore, Md. : 1950) vol. 177 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 28 results.